Masanori Oshi

4.0k total citations
132 papers, 2.8k citations indexed

About

Masanori Oshi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masanori Oshi has authored 132 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 60 papers in Cancer Research and 56 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masanori Oshi's work include Ferroptosis and cancer prognosis (41 papers), Cancer Immunotherapy and Biomarkers (36 papers) and Cancer Genomics and Diagnostics (23 papers). Masanori Oshi is often cited by papers focused on Ferroptosis and cancer prognosis (41 papers), Cancer Immunotherapy and Biomarkers (36 papers) and Cancer Genomics and Diagnostics (23 papers). Masanori Oshi collaborates with scholars based in Japan and United States. Masanori Oshi's co-authors include Kazuaki Takabe, Itaru Endo, Li Yan, Yoshihisa Tokumaru, Ryusei Matsuyama, Mariko Asaoka, Takashi Ishikawa, Omar M. Rashid, Hideo Takahashi and Eriko Katsuta and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Masanori Oshi

121 papers receiving 2.8k citations

Peers

Masanori Oshi
Ferdinandos Skoulidis United States
Marleen Kok Netherlands
Gail S. Wright United States
Ricardo R. Lastra United States
Masanori Oshi
Citations per year, relative to Masanori Oshi Masanori Oshi (= 1×) peers Yoshihisa Tokumaru

Countries citing papers authored by Masanori Oshi

Since Specialization
Citations

This map shows the geographic impact of Masanori Oshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Oshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Oshi more than expected).

Fields of papers citing papers by Masanori Oshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanori Oshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Oshi. The network helps show where Masanori Oshi may publish in the future.

Co-authorship network of co-authors of Masanori Oshi

This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Oshi. A scholar is included among the top collaborators of Masanori Oshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Oshi. Masanori Oshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oshi, Masanori, Farhad Ghasemi, Akimitsu Yamada, et al.. (2025). Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer. Annals of Surgical Oncology. 32(10). 7959–7969.
2.
Oshi, Masanori, Vikas Satyananda, Yan Li, et al.. (2024). Spinster Homologue 2 Expression Correlates With Improved Patient Survival in Hepatocellular Carcinoma Despite Association With Lymph-Angiogenesis. World Journal of Oncology. 15(2). 181–191. 3 indexed citations
3.
Oshi, Masanori, Akimitsu Yamada, Rui Wu, et al.. (2024). Breast cancer in adolescents and young adults has a specific biology and poor patient outcome compared with older patients. ESMO Open. 9(11). 103737–103737. 2 indexed citations
6.
Oshi, Masanori, et al.. (2023). A Case of Aortitis after Administration of G-CSF during Neoadjuvant Chemotherapy for Breast Cancer. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 84(6). 862–867. 1 indexed citations
7.
Oshi, Masanori, Arya Mariam Roy, Osamu Matsuura, et al.. (2023). E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery. 174(2). 307–314. 13 indexed citations
8.
Yamada, Akimitsu, Masanori Oshi, Ikuko Ota, et al.. (2023). Breast carcinoma with spontaneous regression after needle biopsy: a case report and literature review. Gland Surgery. 12(6). 853–859.
9.
Wu, Rongrong, Masanori Oshi, Mariko Asaoka, et al.. (2023). Intratumoral Tumor Infiltrating Lymphocytes (TILs) are Associated With Cell Proliferation and Better Survival But Not Always With Chemotherapy Response in Breast Cancer. Annals of Surgery. 278(4). 587–597. 24 indexed citations
10.
Suzuki‐Minakuchi, Chiho, Akimitsu Yamada, Masanori Oshi, et al.. (2023). Clinicopathological Characteristics and Prognosis of Triple-Negative Apocrine Carcinoma: A Case-Control Study. World Journal of Oncology. 14(6). 551–557.
11.
Wu, Rongrong, Yoshihisa Tokumaru, Mariko Asaoka, et al.. (2022). Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer. Breast Cancer Research and Treatment. 195(1). 17–31. 9 indexed citations
12.
Takeshita, Takashi, Yoshihisa Tokumaru, Masanori Oshi, et al.. (2022). Clinical Relevance of Estrogen Reactivity in the Breast Cancer Microenvironment. Frontiers in Oncology. 12. 865024–865024. 10 indexed citations
13.
Oshi, Masanori, Shipra Gandhi, Fernando A. Angarita, et al.. (2021). A novel five-gene score to predict complete pathological response to neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer.. PubMed Central. 11(7). 3611–3627. 10 indexed citations
14.
Tokumaru, Yoshihisa, Masanori Oshi, Ankit Patel, et al.. (2021). Organoids Are Limited in Modeling the Colon Adenoma–Carcinoma Sequence. Cells. 10(3). 488–488. 13 indexed citations
15.
Oshi, Masanori, Yoshihisa Tokumaru, Fernando A. Angarita, et al.. (2021). Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival. Scientific Reports. 11(1). 12541–12541. 38 indexed citations
16.
Oshi, Masanori, Yoshihisa Tokumaru, Fernando A. Angarita, et al.. (2020). Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer. Cancers. 12(12). 3557–3557. 41 indexed citations
17.
Chouliaras, Konstantinos, Yoshihisa Tokumaru, Mariko Asaoka, et al.. (2020). Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer. Surgery. 169(5). 1234–1239. 18 indexed citations
18.
Tokumaru, Yoshihisa, Eriko Katsuta, Masanori Oshi, et al.. (2020). High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer. International Journal of Molecular Sciences. 21(9). 3045–3045. 38 indexed citations
19.
Takahashi, Hideo, Masanori Oshi, Mariko Asaoka, et al.. (2020). Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers. Annals of Surgical Oncology. 27(11). 4475–4485. 42 indexed citations
20.
Katsuta, Eriko, Masanori Oshi, Omar M. Rashid, & Kazuaki Takabe. (2018). Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy. Journal of Visualized Experiments. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026